NUVL
Nuvalent, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -5.9% ·
share flow +2.1% ·
net new positions -6.2%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | 0 | 28.32M | $3.50B | +16 | −15 |
| Q1 2026 | 98 | +7 | 37.97M | $3.87B | +12 | −6 |
| Q4 2025 | 90 | +2 | 41.80M | $4.20B | +4 | −1 |
| Q3 2025 | 16 | -2 | 30.34M | $2.62B | +1 | −4 |
| Q2 2025 | 16 | -1 | 25.82M | $1.97B | n/a | −1 |
| Q1 2025 | 14 | +1 | 6.74M | $477.77M | +1 | n/a |
| Q4 2024 | 13 | +1 | 7.00M | $548.03M | +1 | n/a |
| Q3 2024 | 11 | +1 | 4.59M | $469.19M | +1 | n/a |
| Q2 2024 | 10 | n/a | 3.29M | $249.85M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 9.97M | n/a | $760.62M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | The Vanguard Group ✦ (passive) | 4.52M | n/a | $345.19M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (passive) | 4.05M | n/a | $308.73M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 4 | T. Rowe Price ✦ | 1.80M | +23.8% | $136.99M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 1.58M | +9.3% | $120.28M | 0.0% | ▲ Add | 5 | SEC ↗ ×7 |
| 6 | State Street Global Advisors ✦ (passive) | 1.49M | +4.2% | $113.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 996.85K | +11.6% | $76.07M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 577.50K | +45.5% | $44.06M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 374.60K | +184.6% | $28.58M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 156.79K | +19.7% | $11.96M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 114.76K | -5.4% | $8.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 63.84K | +70.7% | $4.87M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Marshall Wace ✦ | 61.49K | -85.4% | $4.69M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 33.71K | +241.4% | $2.57M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 15 | Renaissance Technologies ✦ | 29.20K | +1.7% | $2.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 8.96K | -94.4% | $683,572 | 0.0% | ▼ Trim | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Millennium Management | $5.81M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 262 holders, 78.13M shares, $7.62B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.